OR WAIT null SECS
March 02, 2019
Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.
February 19, 2019
In a deal worth $530 million, the companies will develop and commercialize an anti-epileptic drug candidate in Europe.
February 02, 2019
New platform technologies, advanced modeling tools, and addressing patient needs are important developments.
January 02, 2019
Orphan and cancer drugs continue to lead, but treatments for many common diseases were also approved in 2018.
December 02, 2018
Antibody-based drugs offer new mechanisms of action and greater specificity.
November 02, 2018
Demand for highly potent APIs continues to rise.
October 02, 2018
Integration of new modeling and analytical tools with flow chemistry are notable trends.
September 02, 2018
Existing software tools cannot take into account the complexity of disease.
August 02, 2018
Low-temperature chemistry enables performance of more challenging and selective chemistry.
July 02, 2018
With the right excipients, formulators can control when, where, and how an API is released.